ロード中...
The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations
Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the obstructive airway diseases and patients experience worse outcomes compared with asthma or COPD alone. Patients wit...
保存先:
| 出版年: | Expert Rev Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7046086/ https://ncbi.nlm.nih.gov/pubmed/23473596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ecp.13.2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|